NCT03090867

Brief Summary

ICUs have always perceived by the public has a very technical unit with a restricted and/or forbidden access. Physical alteration of the patient, seeing the patient sedated, the large numbers of devices, the alarms and an uncertain prognosis. All this factors can be perceived by people close to the patient as a source of stress. In the literature, numerous studies have shown that families develop anxiety and depression symptoms while their loved one is hospitalized in the ICU. French intensive care societies thought of ways to prevent or diminish these symptoms. The 6th consensus conference on " Live better in the ICU " recommends: effective and adapted information, large visiting hours to reach an unrestricted access and family participation in care. The unit has taken this path to improve patient and family centered care by: creating a welcome leaflet, a room dedicated to meetings with families and an ICU open 24/7bto families, with the possibility for children to visit their parents. Hence, spontaneously, relatives have expressed the wish to participate to certain care and when participating, expressed their satisfaction. This observation and testimonies from family members and patients led us to think about the impact of participation of care. Two major French studies have shown contradictory outcomes: 16% of families would have been willing to participate in the first study against 97% in the second one. These studies were survey done after the ICU discharge. No study today has assessed the actual impact of family participation in care. The aim of this clinical trial is to diminish anxiety and depression symptoms. By participating in care, relatives can develop or strengthen a relationship of trust with caregivers. It could contribute also to a better understanding of the plan of care and an easier context to announce negative outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 27, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

November 16, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

January 28, 2020

Status Verified

January 1, 2020

Enrollment Period

2 years

First QC Date

February 6, 2017

Last Update Submit

January 27, 2020

Conditions

Keywords

Clinical Practice GuidelineCritical careFamily-centered careProfessional-family relationsFamily nursingAnxietyDepressionParticipation in care

Outcome Measures

Primary Outcomes (1)

  • Change from baseline HAD scale at ICU's discharge

    HAD Scale : The primary outcome measure is the relative or surrogate HAD (Hospital Anxiety and Depression Scale) score evolution. The expected result is a reduction by two points of the total HAD score through active participation in care.

    From baseline and at the patient's discharge from the ICU assessed up to 3 months

Secondary Outcomes (6)

  • Evolution of the relative or surrogate anxiety/depression

    at baseline and after 10 days of ICU hospitalization.

  • Evolution of the relative or surrogate anxiety/depression

    at baseline and at ICU's discharge assessed up to 3 months

  • Evaluation of the satisfaction's relatives or surrogates regarding their participation in the ICU patient care by a questionnaire

    At the patient's ICU discharge assessed up to 3 months

  • Evaluation of the satisfaction of the ICU staff by a questionnaire

    Through study completion an average of 12 months

  • Quantify which care have been realized by the relatives or surrogates

    Through study completion an average of 12 months

  • +1 more secondary outcomes

Study Arms (2)

Conventional arm

ACTIVE COMPARATOR

The relative or surrogate will not be encouraged to perform care. The management of the relative or surrogate wi ll not changed from the regular standard of the ICU.

Other: Conventional ,care

The relative/surrogate will be encouraged to perform care

EXPERIMENTAL

The relative or surrogate will perform at least two cares a week . A manual will be given to the relative or surrogate, explaining the different care he can choose to perform on the patient. The care proposed are: feeding, mouth care, hair wash, shaving, eye care, hand, foot and face massage. All care are planned and perform under the supervision or/and in collaboration with a caregiver. Each care is written down on a collecting sheet.

Other: Relatives or surrogates are encouraged to perform care

Interventions

The relative or surrogate will perform at least two cares a week among feeding, mouth care, hair wash, shaving, eye care, hand, foot and face massage. All care are planned and perform under the supervision or/and in collaboration with a caregiver. The relative or surrogate will give his opinion by completing the study questionnaires.

The relative/surrogate will be encouraged to perform care

The relative or surrogate will not be encouraged to perform care. The management of the relative or surrogate wi ll not changed from the regular standard of the ICU.

Conventional arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • An adult related to the ICU patients, giving his written consent to participate to the study
  • Being present at the patient's bedside at least twice a week
  • Speaking and writing comprehension of the french language
  • Adult ICU patient, admitted in the ICU for less than 72 hours, whatever its pathology
  • Predictable ICU stay over a week

You may not qualify if:

  • Refusal of the relative or surrogate
  • Refusal of the patient
  • The relative or surrogate can't be present at the patient's bedside at least twice a week
  • Relative or surrogate already participating in the care of the patient for a chronic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Pitié Salpêtrière

Paris, 75013, France

Location

Related Publications (2)

  • Azoulay E, Pochard F, Chevret S, Arich C, Brivet F, Brun F, Charles PE, Desmettre T, Dubois D, Galliot R, Garrouste-Orgeas M, Goldgran-Toledano D, Herbecq P, Joly LM, Jourdain M, Kaidomar M, Lepape A, Letellier N, Marie O, Page B, Parrot A, Rodie-Talbere PA, Sermet A, Tenaillon A, Thuong M, Tulasne P, Le Gall JR, Schlemmer B; French Famirea Group. Family participation in care to the critically ill: opinions of families and staff. Intensive Care Med. 2003 Sep;29(9):1498-504. doi: 10.1007/s00134-003-1904-y. Epub 2003 Jul 10.

    PMID: 12856124BACKGROUND
  • Garrouste-Orgeas M, Willems V, Timsit JF, Diaw F, Brochon S, Vesin A, Philippart F, Tabah A, Coquet I, Bruel C, Moulard ML, Carlet J, Misset B. Opinions of families, staff, and patients about family participation in care in intensive care units. J Crit Care. 2010 Dec;25(4):634-40. doi: 10.1016/j.jcrc.2010.03.001.

    PMID: 20435430BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Alain COMBES, M.D, Ph.D

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2017

First Posted

March 27, 2017

Study Start

November 16, 2017

Primary Completion

November 15, 2019

Study Completion

February 1, 2020

Last Updated

January 28, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations